Recent News

Plazomicin Shows Promise as New Aminoglycoside Antibiotic

Achaogen Appoints Chief Medical Officer Kenneth Hillan to Chief Executive Officer

SCIENTIFIC & GENERAL PUBLICATIONS/POSTERS

Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals

Emergence of an Autochthonous and Community-Acquired NDM-1–Producing Klebsiella pneumoniae in Europe

Bacterial Resistance
in the News

Warm Weather Increases Hospital Infections, And What That Might Mean For Climate Change

Resistance Is Futile

Xconomy: Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics

---